Literature DB >> 1192634

Unicompartmental polycentric knee arthroplasty: description and preliminary results.

M D Skolnick, R S Bryan, L F Peterson.   

Abstract

Unicompartmental polycentric knee arthoplasty is a procedure that we have performed in relatively few patients whose disease has not been suitable for conventional reconstruction or for total knee replacement. Preoperative and postoperative evaluations and operative technique differ little from that previously published for total knee arthroplasty. One-year follow-up of 14 knees (13 patients) reveals no major complications. These early results encourage further trial of the procedure in selected patients. Unicompartmental arthroplasty is reserved for conditions affecting predominantly one side of the joint. More specific indications are clearly defined and pertain to patients who have osteoarthritis unsuitable for valgus upper tibial osteotomy, condylar fracture and necrosis, and failure of osteotomy and tibial plateau prosthesis.

Entities:  

Mesh:

Year:  1975        PMID: 1192634

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  The clinical outcome of revision knee replacement after unicompartmental knee arthroplasty versus primary total knee arthroplasty: 8-17 years follow-up study of 49 patients.

Authors:  Jaakko Järvenpää; Jukka Kettunen; Hannu Miettinen; Heikki Kröger
Journal:  Int Orthop       Date:  2009-05-27       Impact factor: 3.075

2.  The immediate effect of navigation on implant accuracy in primary mini-invasive unicompartmental knee arthroplasty.

Authors:  Ralf E Rosenberger; Christian Fink; Sebastian Quirbach; Rene Attal; Katja Tecklenburg; Christian Hoser
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-09-20       Impact factor: 4.342

Review 3.  A meta-analysis of unicompartmental knee arthroplasty revised to total knee arthroplasty versus primary total knee arthroplasty.

Authors:  Xuedong Sun; Zheng Su
Journal:  J Orthop Surg Res       Date:  2018-06-22       Impact factor: 2.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.